Figures & data
![Figure 1. AS-derived extract induces the expression of MHC class II, IL12, and IL23 in macrophages rather than peripheral DCs.Note: DO11.10 Balb/c mice were intraperitoneally injected with OVA peptide323–339 (100 µg) plus either vehicle or AS extract (4 µg) three times a week for two weeks. Splenocytes were prepared from both vehicle- or AS extract-treated mice after immunization. Both the MHC class II cell surface and intracellular IL12p40/IL23p19 production levels were measured on macrophages (gated on F4/80+CD11b+CD11c- population) or DCs (gated on CD11c+ population) by flow cytometry. Data are shown as the means ± SD (n = 3; *P ≤ 0.05; **P ≤ 0.01).](/cms/asset/94bf3132-6eeb-4e67-b799-962f5c7aed03/tacs_a_945479_f0001_b.jpg)
![Figure 2. In vivo treatment with AS extracts induces Th1 and Th17 differentiation.Note: After two weeks of immunization, purified splenic CD4+ T cells were activated with plate-bound anti-CD3 (10 µg/ml) and anti-CD28 (1 µg/ml) mAbs for 16 hrs and subsequently restimulated with PMA (50 ng/ml) and ionomycin (1 µg/ml) in the presence of brefeldin A (10 µg/ml) for an additional 2 hrs. (A) The production levels of intracellular IFNγ and IL4 by CD4+ T cells gated on CD4+KJ1-26+ population were measured by flow cytometry. (B) The intracellular IL17 production level by CD4+KJ1-26+ T cells was assessed by flow cytometric analysis. (C) The mRNA levels of T helper cell transcription factors in purified splenic CD4+ T cells from either vehicle- or AS extract-treated mice were analyzed by RT-PCR. Data are shown as the mean ± SD (n = 3; *P ≤ 0.05; **P ≤ 0.01).](/cms/asset/587b541d-02d9-4e56-9577-662c76ea4da4/tacs_a_945479_f0002_b.jpg)
![Figure 3. In vivo treatment with AS extracts upregulates IL17 production by NKT cells and neutrophils.Note: After two weeks of immunization, the intracellular expression levels of IFNγ (A) and IL17 (B) by splenocytes from vehicle- or AS extract-treated mice were measured by flow cytometry gated on DX5+TCRβ− (NK cells), DX5+TCRβ+ (NKT cells), or non-B/non-T (NBNT) Gr-1+CD11b+ (neutrophils) populations. Data are shown as the means ± SD (n = 3; *P ≤ 0.05; **P ≤ 0.01).](/cms/asset/5f579009-e207-4988-a5dc-72164c8458ff/tacs_a_945479_f0003_b.jpg)
![Figure 4. Addition of AS extracts results in a dramatic reduction in the generation of OVA-specific Foxp3+ Treg cells.Note: After two weeks of immunization, total splenocytes from either vehicle- or AS extract-treated mice were prepared and permeabilized for intracellular Foxp3 staining. The intracellular expression of Foxp3 was analyzed by flow cytometry gated on CD4+CD25+KJ1-26+ population. Data are shown as the means ± SD (n = 3; *P ≤ 0.05).](/cms/asset/2e7c3f34-eb1f-4382-b94c-fecb5221a24d/tacs_a_945479_f0004_b.jpg)
Register now or learn more
Free access
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.